Physician profile
Michele Tomasulo
NPI 1336109248
$557.65
in general payments reported to CMS, 2019-2025
16 companies · $19.25 in 2025
The $19.25 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $186 · 2023: $229 · 2024: $123 · 2025: $19.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $117.42 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $86.77 | 2022-2023 | Gardasil 9, Delstrigo, Pifeltro |
| Pfizer INC. | $53.41 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.61 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.79 | 2023 | |
| Abbvie INC. | $27.64 | 2024 | |
| Viiv Healthcare Company | $25.88 | 2024 | Apretude |
| Hologic Sales and Service, LLC | $24.82 | 2024 | Aptima |
| Theratechnologies INC. | $24.57 | 2023 | Egrifta, Trogarzo |
| Novavax INC | $19.48 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Alk-Abello, INC | $17.09 | 2023 | Grastek, Odactra |
| Glaxosmithkline, LLC. | $15.07 | 2022 | |
| Lilly USA, LLC | $14.52 | 2024 | Zepbound, Jardiance |
| Exact Sciences Corporation | $14.42 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $13.46 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Tomasulo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.